Evidence map›Paper›PMID 40858612›Full record

ArticleNature communications2025

SeeThrough: a rationally designed skull clearing technique for in vivo brain imaging.

Xinyi Liu, Motokazu Uchigashima, Ikumi Oomoto, Yoshihito Saito, Hitoshi Uchida, Shinya Oginezawa, Keiko Masuda, Daisuke Satoh, Manabu Abe, Kenji Sakimura and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xinyi Liu *Department of Cellular Neuropathology, Brain Research Institute, Niigata University, Niigata, Japan.
Motokazu Uchigashima *Department of Cellular Neuropathology, Brain Research Institute, Niigata University, Niigata, Japan.ORCID http://orcid.org/0000-0002-0878-2233
Ikumi OomotoCenter for Brain Science, RIKEN, Wako, Saitama, Japan.
Yoshihito SaitoCenter for Brain Science, RIKEN, Wako, Saitama, Japan.ORCID http://orcid.org/0000-0003-3848-9000
Hitoshi UchidaDepartment of System Pathology for Neurological Disorders, Brain Research Institute, Niigata University, Niigata, Japan.ORCID http://orcid.org/0000-0002-8952-2061
Shinya OginezawaDepartment of Cellular Neuropathology, Brain Research Institute, Niigata University, Niigata, Japan.ORCID http://orcid.org/0000-0003-2615-0747
Keiko MasudaLaboratory for Cell-Free Protein Synthesis, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo, Japan.
Daisuke SatohDepartment of Cellular Neuropathology, Brain Research Institute, Niigata University, Niigata, Japan.
Manabu AbeDepartment of Animal Model Development, Brain Research Institute, Niigata University, Niigata, Japan.ORCID http://orcid.org/0000-0001-8534-2138
Kenji SakimuraDepartment of Animal Model Development, Brain Research Institute, Niigata University, Niigata, Japan.
Yoshihiro ShimizuLaboratory for Cell-Free Protein Synthesis, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo, Japan.ORCID http://orcid.org/0000-0003-3499-1394
Masanori MurayamaCenter for Brain Science, RIKEN, Wako, Saitama, Japan. masanori.murayama@riken.jp.ORCID http://orcid.org/0000-0001-7623-010X
Kazuki TainakaDepartment of System Pathology for Neurological Disorders, Brain Research Institute, Niigata University, Niigata, Japan. kztainaka@bri.niigata-u.ac.jp.ORCID http://orcid.org/0000-0002-5943-8723
Takayasu MikuniDepartment of Cellular Neuropathology, Brain Research Institute, Niigata University, Niigata, Japan. tmikuni@bri.niigata-u.ac.jp.ORCID http://orcid.org/0000-0002-9769-9369

Funding

Human Frontier Science Program (HFSP) CDA00043/2019-CJapan Agency for Medical Research and Development (AMED) JP15dm0207001 and JP23wm0625001Japan Agency for Medical Research and Development (AMED) JP19dm0207080, JP21wm0525014 and JP24wm0625117Japan Agency for Medical Research and Development (AMED) JP21wm0425001, JP21zf0127004 and JP24wm0625117Kowa Life Science Foundation N/AMEXT | Japan Society for the Promotion of Science (JSPS) JP20H05914, JP20H05918, JP23K18160 and JP24K02130MEXT | Japan Society for the Promotion of Science (JSPS) JP22H02937 and JP22K19105MEXT | Japan Society for the Promotion of Science (JSPS) JP22K21353, JP23H04672, JP23H02574, JP23K27265, JP24H01229, JP24K22000 and JP25H02490MEXT | Japan Society for the Promotion of Science (JSPS) JP24H02313 and JP20H05775Takeda Science Foundation N/AUehara Memorial Foundation N/A
6 · The paper itself

Abstract

Light scattering in the skull limits optical access to the brain. Here we present SeeThrough, a skull-clearing technique that enables simple, high-resolution, and minimally-invasive brain imaging without skull removal. Through systematic screening of over 1600 chemicals, we rationally developed a refractive index-matching solution that combines water- and organic solvent-based components, achieving both high clearing efficiency and biocompatibility. The reagents exhibit minimal brain penetration, maintain tissue integrity, and avoid inflammatory responses. Notably, SeeThrough provides imaging sensitivity and contrast comparable to open-skull window imaging, while permitting minimally-invasive monitoring of brain border macrophages as well as blood and cerebrospinal fluid dynamics. Combined with two-photon imaging, SeeThrough enables spatially and temporally scalable imaging applications in the mouse brain, including ~400 µm deep imaging, one-month longitudinal imaging, and mesoscale, cellular-resolution monitoring of brain activity for network-level analysis. Thus, SeeThrough offers a broadly accessible platform for high-throughput, physiology-preserving imaging of the brain parenchyma and brain-skull interface.

Indexed as

BrainNeuroimagingSkullAnimalsMaleMiceMice, Inbred C57BL

Identifiers

PMID40858612
PMCPMC12381034

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.